BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

11 articles for TA Lewis

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of ML390: A Human DHODH Inhibitor That Induces Differentiation in Acute Myeloid Leukemia.EBI
Broad Institute
Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies.EBI
TBA
Effect of Inhibiting Histone Deacetylase with Short-Chain Carboxylic Acids and Their Hydroxamic Acid Analogs on Vertebrate Development and Neuronal Chromatin.EBI
Broad Institute of Harvard and Mit
Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell Killing.EBI
Broad Institute of Mit and Harvard
5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.EBI
Ucb Pharma
Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity.EBI
Ucb Pharma
5-lipoxygenase inhibitors with histamine H(1) receptor antagonist activity.EBI
Ucb Pharma
Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction.EBI
The State University of New Jersey
INHIBITORS OF MENIN-MLL INTERACTIONBDB
Bala Therapeutics
Dosage forms and regimens for amino acid compoundsBDB
Pliant Therapeutics
Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist.BDB
Yamanouchi Pharmaceutical